Ketorolac
- Generic Name
- Ketorolac
- Brand Names
- Acular, Acuvail, Omidria, Readysharp Anesthetics Plus Ketorolac, Sprix, Toradol, Toronova Suik
- Drug Type
- Small Molecule
- Chemical Formula
- C15H13NO3
- CAS Number
- 74103-06-3
- Unique Ingredient Identifier
- YZI5105V0L
- Background
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.
...
- Indication
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and has antipyretic, analgesic and anti-inflammatory properties. It is indicated for short term management of acute pain that requires the calibre of pain management offered by opioids. Clinicians may choose to initiate ketorolac to manage post-operative pain, spinal and soft tissue pain, rheumatoid...
- Associated Conditions
- Acute Migraine, Eye Pain, Inflammation, Macular Edema, Cystoid, Ocular Itching, Pericarditis Acute, Pseudophakic Cystoid Macular Oedema, Severe Acute Pain, Acute, moderate Pain, Chronic aphakic cystoid macular edema, Intraoperative miosis, Postoperative ocular pain
- Associated Therapies
- -
A Comparison of NSAIDs for Acute, Non-radicular Low Back Pain.
- Conditions
- Interventions
- First Posted Date
- 2019-03-04
- Last Posted Date
- 2022-05-31
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 198
- Registration Number
- NCT03861611
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Teh Effect of Subgingival Irrigation Wif Ketorolac and Chlorhexidine in Patients Wif Chronic Periodontist
- First Posted Date
- 2019-02-11
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Amirhossein Farahmand
- Target Recruit Count
- 2
- Registration Number
- NCT03836781
- Locations
- 🇮🇷
Amirhossein Farahmand, Tehran, Iran, Islamic Republic of
Nonopioid Analgesia After Labral Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 100
- Registration Number
- NCT03825809
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Lumbar Erector Spinae Plane Block for Back Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Dr M. B. Breebaart
- Target Recruit Count
- 80
- Registration Number
- NCT03825198
- Locations
- 🇧🇪
University Hospital Antwerp, Antwerp, Belgium
🇧🇪AZ KLina, Brasschaat, Antwerp, Belgium
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- St. Louis University
- Target Recruit Count
- 60
- Registration Number
- NCT03823534
- Locations
- 🇺🇸
Saint Louis University, Saint Louis, Missouri, United States
Nonopioid Analgesia After Arthroscopic Meniscus Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 61
- Registration Number
- NCT03820193
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
- Conditions
- Interventions
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 62
- Registration Number
- NCT03818932
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Nonopioid Analgesia After Rotator Cuff Repair
- Conditions
- Interventions
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 70
- Registration Number
- NCT03818919
- Locations
- 🇺🇸
Health Ford Health System, Detroit, Michigan, United States
Effect of Toradol on Post-operative Foot and Ankle Healing
- Conditions
- Interventions
- First Posted Date
- 2018-11-01
- Last Posted Date
- 2018-11-01
- Lead Sponsor
- Rothman Institute Orthopaedics
- Target Recruit Count
- 128
- Registration Number
- NCT03727048
Phase 2 Herniorrhaphy Study for Opioid Elimination
- Conditions
- Interventions
- First Posted Date
- 2018-10-04
- Last Posted Date
- 2021-10-25
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 63
- Registration Number
- NCT03695367
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.